BMS, GSK and Astellas join OKRA to discuss the answer to uncertainty

<p>We live in an increasingly digital world. Even more so following Covid-19. </p><p>As our field forces transition to an online/hybrid model, we start to think not just about the disadvantages but the new advantages this brings.</p><p>One tempting possibility is the promise of ‘next best action’, using AI to give reps direction and guidance on who to approach and how to approach them.</p><p>However, like with all digital implementations, success or failure is dependent on ‘how’ you do it.</p><p>Join <strong>BMS, GSK</strong> and <strong>Astellas</strong> in a discussion with <strong>OKRA</strong> for an essential, <a href=””>free webinar on Tuesday 15th September</a>, to discover the future of pharma sales and why, actually, simply going with ‘next best action’ may not be sufficient.</p><p><strong>Sign up here: <a href=”” target=”_blank” rel=”noopener noreferrer” data-saferedirecturl=””></a></strong></p><p>For more information or if you have any questions, please contact Rasim Shah, Director at OKRA on</p>

This webinar has been featured by The Pharmaceutical Marketing Group. Interested in working with us? Contact our webinar division at

Subscribe to our Newsletter today!You have the chance to win a $50 gift card

Subscribe to our Newsletter today and we let you know if you are the happy winner of our monthly raffle.